Combining lapatinib (GW572016), a small molecule inhibitor of ErbB1 and ErbB2 tyrosine kinases, with therapeutic anti-ErbB2 antibodies enhances apoptosis of ErbB2-overexpressing breast cancer cells
Keyword(s):
Keyword(s):
2014 ◽
Keyword(s):
2020 ◽
2004 ◽
Vol 64
(21)
◽
pp. 7947-7953
◽
Keyword(s):
Keyword(s):
2009 ◽
Keyword(s):
Keyword(s):